Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening

International Journal of Cancer

Volumn 136, Issue 3, 2015, Pages 646-655

  Bosgraaf, Remko P ^a   Verhoef, Viola M J ^b   Massuger, Leon F A G ^a   Siebers, Albert G ^a   Bulten, Johan ^a   De Kuyper De Ridder, Gabriëlle M ^a   Meijer, Chris J M ^b   Snijders, Peter J F ^b   Heideman, Daniëlle A M ^b   IntHout, Joanna ^a   Van Kemenade, Folkert J ^c   Melchers, Willem J G ^a   Bekkers, Ruud L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Non responders; Participation; Population based cervical screening; Self sampling

Indexed keywords

ADULT; ARTICLE; BRUSH BASED SELF SAMPLING DEVICE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GYNECOLOGICAL AND OBSTETRIC EQUIPMENT; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION RISK; INVESTIGATIVE PROCEDURES; LAVAGE BASED SELF SAMPLING DEVICE; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF SAMPLING METHOD; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; COMPARATIVE STUDY; EARLY DIAGNOSIS; FOLLOW UP; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 84911007626     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29026     Document Type: Article

References (52)

1. Louhivuori K. Effect of a mass screening program on the risk of cervical cancer. Cancer Detection Prevent 1991;15:471-5.
2. Macgregor JE, Campbell MK, Mann EM, et al. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. Br Med J 1994;308: 1407-11.
3. Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. Br Med J 1999;318:1244-5.
4. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999; 81:159-66.
5. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
6. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996;73:1001-5.
7. de Bie RP, Vergers-Spooren HC, Massuger LF, et al. Patients with cervical cancer: why did screening not prevent these cases? Am J Obstet Gynecol 2011;205:64 e1-e7.
8. Bos AB, Rebolj M, Habbema JD, et al. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006;119:2372-5.
9. Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Br Med J 2010;340:c1040.
10. Gok M, van Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer 2012;130:1128-35.
11. Virtanen A, Anttila A, Luostarinen T, et al. Selfsampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011;128:2681-7.
12. Virtanen A, Nieminen P, Luostarinen T, et al. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prevent 2011;20:1960-9.
13. Wikstrom I, Lindell M, Sanner K, et al. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011;105:337-9.
14. Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 2011;104:915-20.
15. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011;104:248-54.
16. Sancho-Garnier H, Tamalet C, Halfon P, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013;133:2681-7.
17. Sanner K, Wikstrom I, Strand A, et al. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009;101:871-4.
18. Bekkers RL, Massuger LF, Bulten J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004;14:95-105.
19. Bekkers RL, Meijer CJ, Massuger LF, et al. Effects of HPV detection in population-based screening programs for cervical cancer: a Dutch moment. Gynecol Oncol 2006;100:451-4.
20. Schmeink CE, Bekkers RL, Massuger LF, et al. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011;21:139-53.
21. Snijders PJ, Verhoef VM, Arbyn M, et al. Highrisk HPV testing on self-sampled versus cliniciancollected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132: 2223-36.
22. Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on selfcollected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172-83.
23. Letter to the House of Representatives of the Dutch parliament: improvement of the Dutch cervical cancer screening [Brief aan de Tweede Kamer: Verbetering bevolkingsonderzoek baarmoederhalskanker]. Ministry of Health, Welfare and Sport, 2013. http://www. rijksoverheid.nl/documenten-en-publicaties/kamerstukken/2013/10/17/kamerbrief-oververbetering-bevolkingsonderzoek-baarmoe derhalskanker.html.
24. Dijkstra MG, Heideman DA, van Kemenade FJ, et al. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN. J Clin Virol 2012;54:147-51.
25. Jones HE, Brudney K, Sawo DJ, et al. The acceptability of a self-lavaging device compared to pelvic examination for cervical cancer screening among low-income women. J Women's Health 2012;21:1275-81.
26. Igidbashian S, Boveri S, Spolti N, et al. Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt.) 2011;20: 397-402.
27. Szarewski A, Cadman L, Ashdown-Barr L, et al. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screening 2009;16:193-8.
28. van Baars R, Bosgraaf RP, ter Harmsel BW, et al. Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol 2012;50:3937-43.
29. de Roda Husman AM, Snijders PJ, Stel HV, et al. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995;72: 412-7.
30. Bulk S, Van Kemenade FJ, Rozendaal L, et al. The Dutch CISOE-a framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004;57:388-93.
31. Rebolj M, van Ballegooijen M, Berkers LM, et al. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007; 120:806-12.
32. Bosgraaf RP, Mast PP, Struik-van der Zanden PH, et al. Overtreatment in a see-and-treat approach to cervical intraepithelial lesions. Obstet Gynecol 2013;121:1209-16.
33. Hopman EH, Kenemans P, Helmerhorst TJ. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Survey 1998;53:97-106.
34. Gok M, Heideman DA, van Kemenade FJ, et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening program: characteristics of the responders. Eur J Cancer 2012;48:1799-808.
35. Piaggio G, Elbourne DR, Pocock SJ, et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594-604.
36. Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on selfsampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120:1505-10.
37. Bosgraaf RP, Ketelaars PJ, Verhoef VM, et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prevent Med 2014;64:108-113.
38. Landelijk Evaluatieteam voor bevolkingsonderzoek naar Baarmoederhalskanker. [National Evaluation team for cervical cancer screening] LEBA-rapportage. http://www.rivm.nl/Documenten-en-publicaties/Algemeen-Actueel/Uitgaven/Preventie-Ziekte-Zorg/ baarmoederhalskankerscreening/LEBA-rapportage-t-m-2011.
39. Verhoef VM, Bosgraaf RP, van Kemenade FJ, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled noninferiority trial. Lancet Oncol 2014;15:315-22.
40. Barata PC, Mai V, Howlett R, et al. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynaecol 2008;29:251-7.
41. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. The pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11:265-75.
42. Forrest S, McCaffery K, Waller J, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screening 2004;11:85-8.
43. Harper DM, Noll WW, Belloni DR, et al. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73.
44. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-9.
45. Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screening 2006;13: 208-13.
46. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-72.
47. Rijkaart DC, Berkhof J, Rozendaal L, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012; 13:78-88.
48. Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30:(Suppl 5):F88-F99.
49. Eijsink JJ, Yang N, Lendvai A, et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol 2011;120:280-3.
50. Twu NF, Yen MS, Lau HY, et al. Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling. Eur J Obstet Gynecol Reprod Biol 2011;156:96-100.
51. Tamalet C, Richet H, Carcopino X, et al. Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France. J Med Virol 2010;82:1431-7.
52. Bosgraaf RP, Siebers AG, De Hullu JA, et al. The current position and the future perspectives of cervical cancer screening. Expert Rev Anticancer Ther 2014;14:75-92.